Assessment of eyebright (Euphrasia officinalis L.) extract activity in relation to human corneal cells using in vitro tests

Balkan Medical Journal

Volumn 31, Issue 1, 2014, Pages 29-36

  Paduch, Roman ^a   Woźniak, Anna ^b   Niedziela, Piotr ^c   Rejdak, Robert ^b  

^a Department of Virology and Immunology ^*  (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Establishment District Railway Hospital   (Poland)

Author keywords

Cytotoxicity; Euphrasia officinalis extracts; Human corneal cells; Immunomodulation; Reactive oxygen species scavenging effect

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIOXIDANT; ASCORBIC ACID; EUPHRASIA OFFICINALIS EXTRACT; F ACTIN; HEPTANE; IMMUNOMODULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; PLANT EXTRACT; TROLOX C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA CELL; CYTOTOXICITY; DPPH RADICAL SCAVENGING ASSAY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EUPHRASIA; EUPHRASIA OFFICINALIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MTT ASSAY; SOLVENT EFFECT;

EID: 84898872580     PISSN: 21463123     EISSN: 21463131     Source Type: Journal    
DOI: 10.5152/balkanmedj.2014.8377     Document Type: Article

References (25)

1. Petrichenko VM, Sukhinina TV, Babiyan LK, Shramm NI. Chemical composition and antioxidant properties of biologically active compounds from Euphrasia brevipila. Pharm Chem J 2006;40:312-6. [CrossRef]
2. Stoss M, Michels C, Peter E, Beutke R, Gorter RW. Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis. J Altern Complement Med 2000;6:499-508. [CrossRef]
3. Blazics B, Alberti A, Kéry A. Antioxidant activity of different phenolic fractions separated from Euphrasia rostkoviana Hayne. Acta Pharm Hung 2009;79:11-6.
4. Citarasu T. Herbal biomedicines: a new opportunity for aquaculture industry. Aquacult Int 2010;18:403-14. [CrossRef]
5. Kozłowski J, Krajewska A. Ziele świetlika jako leczniczy surowiec roślinny. Farm Pol 1982;38:471-4 (in polish).
6. Porchezhian E, Ansari SH, Shreedharan NKK. Antihyperglycemic activity of Euphrasia officinale leaves. Fitoterapia 2000;71:522-6. [CrossRef]
7. Ríos JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol 2005;100:80-4. [CrossRef]
8. Trovato A, Monforte MT, Forestieri AM, Pizzimenti F. In vitro antimycotic activity of some medicinal plants containing flavonoids. Boll Chim Farm 2000;139:225-7.
9. Dharma P, Singh G. A Review of Plant Species Used to Treat Conjunctivitis. Review article. Phytother Res 2002;16:1-22. [CrossRef]
10. Bielory L, Heimall J. Review of complementary and alternative medicine in treatment of ocular allergies. Curr Opin Allergy Clin Immunol 2003;5:395-9. [CrossRef]
11. Aburjai T, Natsheh FM. Plants used in cosmetics. Phytother Res 2003;17:987-1000. [CrossRef]
12. Ganbold M, Barker J, Ma R, Jones L, Carew M. Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC. J Ethnopharmacol 2010;131:396-403. [CrossRef]
13. Paduch R, Matysik G, Wójciak-Kosior M, Kandefer-Szerszeń M, Skalska-Kamińska A, Nowak-Kryska M, et al. Lamium album extracts express free radical scavenging and cytotoxic activities. Polish J Environ Stud 2008;17:569-80.
14. Revoltella RP, Papini S, Rosellini A, Michelini M. Epithelial stem cells of the eye surface. Cell Prolif 2007;40:445-61. [CrossRef]
15. Wylegała E, Dobrowolski D, Nowińska A, Tarnawska D. Anterior segment optical coherence tomography in eye injuries. Graefes Arch Clin Exp Ophthalmol 2009;247:451-5. [CrossRef]
16. Chana HS, Schwab L, Foster A. With an eye to good practice. Traditional healers in rural communities. World Health Forum 1994;15:144-6.
17. West AL, Fetters MD, Hemmila MR, Gorenflo DW, Kiyota A, Moroi-Fetters S. Herb and vitamin supplementation use among a general ophthalmology practice population. Am J Ophthalmol 2005;139:522-9. [CrossRef]
18. Calixto JB, Campos MM, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004;70: 93-103. [CrossRef]
19. Shestakova TS, Petrichenko VM, Sukhinina TV. Elemental composition of Euphrasia brevipila herbs and extracts. Pharm Chem J 2008;42: 460-2. [CrossRef]
20. Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001;45 (Suppl. 2):S211-20. [CrossRef]
21. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-301. [CrossRef]
22. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003;44:124-9. [CrossRef]
23. Achike FI, Kwan Ch-Y. Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 2003;30:605-5. [CrossRef]
24. Kim PKM, Zamora R, Petrosko P, Billiar TR. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001;1:1421-41. [CrossRef]
25. Schmitt ChA, Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 2009;21:77-91. [CrossRef]